TBPH Theravance Biopharma Inc Future Profit

Official company branding of Theravance Biopharma Inc (TBPH)

Stable royalties ensure predictable cash flows for Theravance Biopharma (TBPH). The business model relies on outsourcing distribution and the commercial scaling of drugs through major partners, maintaining a strategic focus on R&D. The company's earnings expectations confirm this approach, with the current mark standing at 0.09. Investors' pragmatic perception solidifies its status as a reliable developer of respiratory therapy treatments.

theravance.com (TBPH): Expected Net Profit from 07/04/2022 to 10/10/2026

Theravance - analytical breakdowns and key metrics (TBPH)

- share price and consensus valuation forecast:
Fundamental company analysis:TBPH, Theravance Biopharma, Inc.
Finished products of Theravance Biopharma Inc

For Theravance Biopharma (TBPH), which relies on fundamental R&D stability and an academic approach to drug development, an analysis of projected financial results allows for an assessment of the effectiveness of long-term investments in scientific personnel. This indicator synthesizes market expectations for net income, transforming the daily balance of supply and demand into a vector of future capital value, which helps investors recognize an overbought asset in a timely manner.

Competitor analysis for Theravance Biopharma

Future Profit HLN|Projected Future Earnings Kenvue Corp|Future Profit VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Expected Net Income|Expected Profit Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Expected Net Profit|PRGO: Future Profit|Alvotech SA - Future Net Profit|LQDA: Projected Future Earnings|Galapagos Genomics - Expected Net Income|ANIP (ANI Pharmaceuticals Inc) - Projected Future Earnings|Expected Net Profit mannkindcorp.com MNKD|Expected Profit Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Expected Net Income|Projected Future Earnings SPRY (ARS Pharmaceuticals Inc)|Projected Future Earnings Aquestive Corp AQST|scPharmaceuticals - Projected Future Earnings|Expected Net Profit tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Expected Profit|SXTC - Company Profit Forecast|Expected Profit eupraxiapharma.com|BHST: Expected Net Income|Future Profit EXOZ (Invizyne Technologies)|ORMP - Expected Net Profit|Projected Future Earnings ENTX (Entera Bio Ltd)|Projected Future Earnings MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Projected Future Earnings|CPIX: Expected Profit|QNTM (Quantum BioPharma Ltd) - Future Profit|Net Profit Forecast FGEN|Expected Profit Telomir Pharmaceuticals|RANI: Expected Net Income|Projected Future Earnings SNYR|Future Profit Rallybio Corp RLYB|Expected Profit Lexaria Bioscience Corp. LEXX|Company Profit Forecast pulmatrix.com (PULM)|Pheton Holdings Limited - Projected Future Earnings|Forward Earnings APM|LYRA (Lyra Therapeutics Inc.) - Future Profit|IBO - Company Profit Forecast|Future Profit TNFA|Net Profit Forecast YCBD (cbdmd.com)|Future Profit PRFX (PainReform Ltd)|CYTO: Forward Earnings|Projected Future Earnings LIPO (lipella.com)|Future Net Profit OPTN (OptiNose Corp)|PIRS: Future Profit|PROC - Projected Future Earnings|PTPI: Projected Future Earnings|Qilian International Holding Group (QLI) - Projected Future Earnings|SLRN (ACELYRIN, Inc.) - Projected Future Earnings|TFF Pharmaceuticals (TFFP) - Company Profit Forecast